Smaller, denser LDL particles are not a risk factor for cardiovascular disease in healthy nonagenarian women of the Cremona Population Study

Atherosclerosis

Volumn 140, Issue 1, 1998, Pages 65-70

  Ruotolo, G ^a,c   Tettamanti, C ^a   Garancini, M P ^a   Ragogna, F ^a   Derosa, G ^a   Nardecchia, L ^b   Parlato, F ^b   Pozza, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CREMONA HOSPITAL   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apolipoprotein E phenotype; HDL particles; LDL particles; Nonagenarians; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; AGING; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; ITALY; LIPOPROTEIN BLOOD LEVEL; PARTICLE SIZE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS E; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; HUMANS; ITALY; LIPOPROTEINS, LDL; MIDDLE AGED; PHENOTYPE; RISK FACTORS;

EID: 0032171263     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00110-5     Document Type: Article

References (30)

1. Pekkanen J., Nissinen A., Puska P., Punsar S., Karvonen M.J. Risk factors and 25 year risk of coronary heart disease in a male population with a high incidence of the disease: the Finnish cohorts of the Seven Countries Study. Br Med J. 299:1989;81-85.
2. Shen M.M., Krauss R.M., Lindgren F.T., Forte T.M. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res. 22:1981;236-244.
3. Krauss R.M., Burke D.J. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 23:1982;97-104.
4. McNamara J.R., Campos H., Ordovas J.M., Peterson J., Wilson P.W., Schaefer E.J. Effects of gender, age, and lipid status on low-density lipoprotein subfraction distribution: results from the Framingham Offspring Study. Arteriosclerosis. 7:1987;483-490.
5. Williams P.T., Vranizan K.M., Krauss R.M. Correlations of plasma lipoproteins with LDL subfractions by particle size in men and women. J Lipid Res. 33:1992;765-774.
6. Austin M.A., Breslow J.L., Hennekens C.H., Buring J.E., Willet W.C., Krauss R.M. Low density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc. 260:1988;1917-1921.
7. Selby J.V., Austin M.A., Newman B., Zhang D., Quesenberry C.P. Jr., Mayer E.J., Krauss R.M. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 88:1993;381-387.
8. Austin M.A., King M.C., Vranizan K.M., Newman M.C., Newman B., Krauss R.M. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 43:1988;838-846.
9. Haffner S.M., Stern M.P., Miettinen H., Robbins D., Howard B.V. Apolipoprotein E polymorphism and LDL size in a biethnic population. Arterioscler Thromb Vasc Biol. 16:1996;1184-1188.
10. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
11. Newschaffer C.J., Bush T.L., Hale W.E. Aging and total cholesterol levels: cohort, period, and survivorship effects. Am J Epidemiol. 136:1992;23-34.
12. Shipley M.J., Pocock S.J., Marmot M.G. Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall Study. Br Med J. 303:1991;89-92.
13. Garancini M.P., Calori G., Ruotolo G., Manara E., Izzo A., Ebbli E., Bozzetti A.M., Boari L., Lazzari P., Gallus G. Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study. Diabetologia. 38:1995;306-313.
14. Parra H.J., Mezdour H., Ghalim N., Bard J.M., Fruchart J.C. Differential electroimmunoassay on ready to use plates for human Lp A-I lipoprotein particles. Clin Chem. 36:1990;1431-1435.
15. Kataoka S., Paidi M., Howard B.V. Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype. Clin Chem. 40:1994;11-13.
16. Edwards K.L., Austin M.A., Newman B., Mayer E.J., Krauss R.M., Selby J.V. Multivariate analysis of the insulin resistance syndrome. Arterioscler Thromb Vasc Biol. 14:1994;1940-1945.
17. Haffner S.M., Mykkanen L., Robbins D., Valdez R., Miettinen H., Howard B.V., Stern M.S., Bowsher R. A preponderance of small, dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome. Diabetologia. 38:1995;1328-1336.
18. Singh A.T.K., Rainwater D.L., Haffner S.M., VandeBerg J.L., Shelledy W.R., Moore P.H. Jr., Dyer T.D. Effect of diabetes on lipoprotein size. Arterioscler Thromb Vasc Biol. 15:1995;1805-1811.
19. Gylling H., Strandberg T., Tilvis R., Miettinen T.A. Regulation of serum cholesterol level in middle-aged and elderly men. Arterioscler Thromb Vasc Biol. 14:1994;694-700.
20. Schaefer E.J., Lamon-Fava S., Johnson S., Ordovas J.M., Schaefer M.M., Castelli W.P., Wilson P.W.F. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels, results from the Framingham Offspring Study. Arterioscler Thromb. 14:1994;1105-1113.
21. The Strong Heart Study Investigators, Kataoka S., Robbins D.C., Cowan L.D., Go O., Yeh J.L., Devereux R.B., Fabsetz R.R., Lee E.T., Welty T.K., Howard B.V. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study. Arterioscler Thromb Vasc Biol. 16:1996;918-925.
22. Zhao S.P., Verhoeven M.H., Vink J., Hollaar L., van der Laarse A., de Knijff P., van't Hooft F.M. Relationship between apolipoprotein E and low density lipoprotein particle size. Atherosclerosis. 102:1993;147-154.
23. Jarvik G.P., Austin M.A., Fabsitz R.R., Auwerx J., Reed T., Christian J.C., Deeb S. Genetic influences on age-related change in total cholesterol, low density lipoprotein cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects. Genet Epidemiol. 11:1994;375-384.
24. Haviland M.B., Lussier-Cacan S., Davignon J., Sing C.F. Impact of apolipoprotein E genotype variation on means, variances, and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenarians. Am J Med Genet. 58:1995;318-331.
25. Kuusisto J., Mykkanen L., Kervinen K., Kesäniemi A., Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol. 15:1995;1280-1286.
26. Heckers H., Burkard W., Schmahl F.W., Fuhrmann W., Platt D. Hyper-alpha-lipoproteinemia and hypo-beta-lipoproteinemia are not markers for a high life expectancy. Gerontology. 28:1982;176-202.
27. Nicholson J., Gartside P.S., Siegel M., Spencer W., Steiner P.M., Glueck C.J. Lipid and lipoprotein distributions in octo- and nonagenarians. Metabolism. 28:1979;51-55.
28. Alvarez C., Orejas A., Gonzalez S., Diaz R., Colomo L.F. Reference interval for serum lipids, lipoproteins and apoproteins in the elderly. Clin Chem. 30:1984;404-406.
29. Luc G., Bard J.M., Lussier-Cacan S., Bouthillier D., Parra H.J., Fruchart J.C., Davignon J. High-density lipoprotein particles in octogenarians. Metabolism. 40:1991;1238-1243.
30. Campbell A.J., Busby W.J., Robertson M.C. Over 80 years and no evidence of coronary heart disease: characteristics of a survivor group. J Am Geriatr Soc. 41:1993;1333-1338.